Avaliação da expressão do mRNA do GLUT 4 em corpo lúteo de cadelas sadias ao longo do diestro

Abstract

HOMA apresentou-se mais alto aos 40 dias, associado aos menores valores de expressão do GLUT4. Por outro lado, obtivemos o pico de expressão de GLUT4 aos 50 dias, quando o índice HOMA apresentou valores baixos. Sugere-se que a queda da P4 associada à elevação do estradiol plasmático possa influenciar o índice HOMA. Pode-se concluir que a expressão do GLUT4 no corpo lúteo de cadelas segue o padrão observado para tecidos sensíveis à insulina, nos quais existe uma maior expressão durante a fase de maior sensibilidade à insulina e diminuição drástica em fase de pré ou já instalada resistência insulínica.Palavras-chave: Cadelas. Diestro. GLUT4. PCR tempo real. The canine estral cycle differs from other domestic species. Some studies demonstrated that the increase of the plasmatic concentration of progesterone during canine luteinic phase can lead to metabolic alterations, such as insulinic resistance and may cause complications such as Diabetes mellitus. Glucose is a molecule that is transported in most cells by transporting proteins. The process of installation of the insulinic resistance is characterized by tissue alterations of the expression of some glucose transporting proteins, as GLUT4. Currenly, 13 isoforms of transporting proteins were sequenced (GLUT1 to GLUT13). GLUT4 is present mainly in muscle and fat tissue. In order to assess if GLUT4 expression is present in luteal cells, and if this expression is related to P4 and E2 production, 28 bitches were divided into 7 groups, in accordance with the days after the ovulation -p.o. (from 10 to 70 days, n=4 for group). The ovaries were dissected and frozen in liquid nitrogen. The RNA was extracted and the cDNA was made and submitted to real time PCR. GAPDH gene was used as endogenous conntrol to standardization of target gene expression. Blood was collected to glycemia, insulinemia, P4, and E2β dosage. To assess the positive regulation of GLUT4, we also assessed HIF-1α mRNA